Twitter Linkedin-in

Preclinical Immuno-Oncology: Online

18 May 2022 | BST (UTC+1)
Part of the
Immuno Series
Preclinical Immuno-Oncology:
Online
Immuno UK:
In-Person
Immuno US:
In-Person
Tumor Microenvironment:
In-Person
Book Now

Preclinical Immuno-Oncology: Online has now concluded. Please click here for more information on other events within our Immuno Series, taking place throughout the year.

Preclinical Immuno-Oncology
18 May 2022 | BST (UTC+1)
Download Agenda
Register

Covering key areas of interest within preclinical immuno-oncology, this interactive online conference is designed for immunotherapy experts to stay up to date with the latest models and approaches impacting their workflow. Discuss innovative approaches to preclinical development, with a focus on preventing translational failures through the development of predictive and robust preclinical models.

Programme

Benefits to Attending...

  • Covering key areas of interest within preclinical immuno-oncology, this interactive online conference is designed for immunotherapy experts to stay up to date with the latest models and approaches impacting their workflow
  • Discuss innovative approaches to preclinical development, with a focus on preventing translational failures through the development of predictive & robust preclinical models
  • Benefit from additional sessions on preclinical challenges, including safety & efficacy considerations
  • Interact with fellow attendees and speakers during the live group Q&As, allowing you to join the conversation and pose your questions to our panel of experts

Agenda at a Glance

  • Advanced model selection to ensure clinical success:
       » Humanised mouse models
       » Syngeneic & Xenographic models
       » 3D Models & Organoids
  • Leveraging predictive and physiologically relevant cellular and animal models
  • How can cutting-edge preclinical models impact biomarker identification
  • Improving success rates in the clinic
  • Preclinical case studies from leading immunotherapy companies – cell therapies, antibodies, oncolytic viruses
  • Preclinical identification and validation of immuno-oncology targets
  • Preclinical strategies for combination therapies
  • Improving safety & overcoming toxicity challenge
  • Novel exploratory and translational biomarkers impacting preclinical research
  • Emerging clinical assays to advance new agent discovery & development, and to improve patient outcomes
  • Predictive biomarkers of response, toxicity and resistance to immunotherapy
  • Liquid biopsies in immuno-oncology

Pre-Event Webinars

You don't have to wait until July to get involved - register for our complimentary live webinars here.
Presented by our expert speakers, these webinars will give you advance insight into topics that will be covered at the event.

Key Speakers

Preclinical Immuno-Oncology: Online brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook

Below are some of our confirmed speakers for Preclinical Immuno-Oncology: Online 2022

Peter Joyce

Peter Joyce

Chief Executive Officer
Grey Wolf Therapeutics
Dirk Brockstedt

Dirk Brockstedt

Chief Scientific Officer
RAPT Therapeutics
Thierry Guillaudeux

Thierry Guillaudeux

Senior Vice President, Immuno-Oncology
Kineta, Inc.
Genevive Hernandez

Genevive Hernandez

Senior Director, Clinical Biomarkers, Clinical Research and Development
IGM Biosciences
Stephanie Casey Parks

Stephanie Casey Parks

Senior Scientist, Pharmacology
Amgen
Pravin Kaumaya

Pravin Kaumaya

Professor
Ohio State University

Event Features​

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of virtual experiences.

Live and On-Demand Presentations

Benefit from the insight of our expert speakers via pre-recorded presentations and interactive live presentations

Virtual Conference Platform

Our fully featured platform offers an immersive conference experience, delivering all the benefits of an in-person event

Digital Networking Opportunities

Connect directly with other registrants of event around the world through direct 1-2-1 chat, video chat and group discussion

Sponsorship

A range of customisable opportunities for lead generation, brand building and global business deals. Whether you’re looking to build business, product launch or increase visibility, we provide a variety of highly effective options to suit budget and requirement.
Download Brochure
There was a good mix of science and company presentations with focus on new technologies.
Vice President Process DevelopmentAchilles Therapeutics
The event featured super interesting talks, cutting edge topics and very relevant clinical data. Great overview of new technologies. I found the round tables very interesting and useful. The event provided complete update on the field of Immuno-Oncology.
ScientistImmunocore
I enjoyed learning about new technologies to address Fc crosslinking problem for costimulatory receptors on T cells and about novel approaches to immunotherapy, such as neutrophils attacking tumour cells.
Senior ScientistCancer Research UK
We have received very good support from Oxford Global when organising our one to one client meetings.
Sales Manager EMEAPersonalis
The congress was well organised and very good for networking opportunities with prospective clients.
Product ManagerCharles River

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.

Download Brochure

Full details regarding the Immuno Series UK are available for download in the Conference Brochure

Read Now